Arbutus Biopharma Q1 EPS $(0.10) Beats $(0.11) Estimate, Sales $1.53M Miss $2.15M Estimate

Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.53 million which missed the analyst consensus estimate of $2.15 million by 28.74 percent. This is a 77.09 percent decrease over sales of $6.69 million the same period last year.